Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
Authors:
Open Access
- 20 November 2023
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (2) , 2282181
Abstract
Purpose: To assess the impact of neoadjuvant chemotherapy (NACT) on the tumor immune microenvironment (TIME) in gynaecological tumors, with a focus on understanding the potential for enhanced combination therapies.Methods: We systematically queried the PubMed, Embase, and Cochrane databases, encompassing reviews, clinical trials, and case studies, to undertake a thorough analysis of the impact of NACT on the TIME of gynaecological tumors.Results: NACT induces diverse immune microenvironment changes in gynaecological tumors. In cervical cancer, NACT boosts immune-promoting cells, enhancing tumor clearance. Ovarian cancer studies yield variable outcomes, influenced by patient-specific factors and treatment regimens. Limited research exists on NACT's impact on endometrial cancer's immune microenvironment, warranting further exploration. In summary, NACT-induced immune microenvironment changes display variability. Clinical trials highlight personalized immunotherapy's positive impact on gynaecological tumor prognosis, suggesting potential avenues for future cancer treatments. However, rigorous investigation is needed to determine the exact efficacy and safety of combining NACT with immunotherapy.Conclusion: This review provides a solid foundation for the development of late-stage immunotherapy and highlights the importance of therapeutic strategies targeting immune cells in TIME in anti-tumor therapy.Keywords
This publication has 142 references indexed in Scilit:
- Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with CarboplatinThe Journal of Immunology, 2013
- Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapyJournal of Cancer Research and Clinical Oncology, 2012
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954Journal of Clinical Oncology, 2010
- In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 daysBlood, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- NK Cell Activity in the Presence of IL-12 Is a Prognostic Assay to Neoadjuvant Chemotherapy in Cervical CancerGynecologic Oncology, 2000
- Complete Response of a Stage IV Uterine Papillary Serous Carcinoma to Neoadjuvant Chemotherapy with Taxol and CarboplatinGynecologic Oncology, 1999
- Complete Clinical Responses to Neoadjuvant Chemotherapy for Uterine Serous CarcinomaGynecologic Oncology, 1999
- Neoadjuvant Chemotherapy in Uterine Papillary Serous CarcinomaGynecologic Oncology, 1996
- Clinical cancer research: An embattled speciesCancer, 1982